The global intubation tubes market size was estimated at USD 2.6 billion in 2022 and is expected to witness a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. The increasing prevalence of hospital-acquired infections such as ventilator-associated pneumonia and rising admissions in the healthcare settings such as hospitals and clinics are propelling the revenue of the market. The beginning of COVID-19 resulted in significant revenue losses, especially in the first and second quarters of 2020. In March 2020, there was a rapid increase in critically ill patients diagnosed with the COVID-19 virus requiring emergency intubation tubes at various healthcare centers. Intubation tubes are the approved way of providing breathing support to COVID-19 patients.
According to clinical guidelines from the American Society of Anesthesiologists, non-invasive mechanical ventilation like CPAP machines used for sleep apnea is not compatible with COVID-19 patients. Intubation tubes and ventilation supports a COVID-19 patient's breathing so the body can survive until the immune system fights the virus.
Some of the most common respiratory diseases are pulmonary hypertension, asthma, chronic obstructive pulmonary disease (COPD), and occupational lung diseases. In addition to tobacco smoke, other risk factors include occupational chemicals and dust, air pollution, and frequent lower respiratory infections during childhood. COPD is one of the world's leading causes of death. The proportion of all deaths caused by lung diseases is influenced by population age and age-specific death rates from respiratory and non-respiratory causes.
Ventilator-associated pneumonia (VAP) is an infection of the lower respiratory tract that occurs after 48 hours of mechanical ventilation. Despite significant advances in diagnostic techniques and management, the morbidity and mortality rates associated with VAP remain high. VAP is reported to affect 5-40% of patients receiving invasive mechanical ventilation for more than 2 days, with large variations depending on criteria used to identify VAP, country, and ICU type.
VAP rates have been reported to be as low as 2.5 cases per 1000 ventilator days in North American hospitals. On the other hand, European centers reported much higher rates. VAP is still one of the most common ICU-acquired infections, and it is linked to increased mortality. Moreover, apart from VAP, the procedure of intubation tube is generally safe and common in a healthcare setting that can help save a patient’s life. Most patients improve in a few hours or days, but some people experience vomiting, breathing problems, or infections.
The trachea intubation segment held the largest revenue share of 82.8% in 2022. Based on product type, the market is segmented into trachea intubation and gastric intubation. Tracheal intubation maintains a patent airway, preventing obstruction caused by loss of consciousness, edoema, or compression. The most common method of tracheal intubation is rigid direct laryngoscopy. It is an urgent need of creating standardized evidence-based protocols for airway management in the ICU. As a result, implementing an intubation care bundle, as well as a pre-planned approach to difficult airways, is critical for safe TI in the ICU.
The gastric intubation segment is expected to exhibit the highest growth of 7.1% over the forecast period. The growth can be attributed to the fact that it is a tube that is inserted in the patient’s nose, down to the throat and esophagus, and ends in the stomach. It is also used to provide liquid food, medications, and liquids, as well as to remove elements from the stomach. A gastric intubation insertion is typically performed in a hospital or at home, and it also allows the doctor to treat an intestinal obstruction in less invasive ways than intestinal surgery.
The hospitals segment held the largest revenue share of 67.9% as of 2022. With the growing demand for surgeries performed annually, the number of patient admissions is increasing. The high number of users are patients with chronic conditions or severe illnesses and the high flow of patients into the hospitals for treatment and are the factors to support the segment growth. According to the statistics of Statista, in 2019, there were over 36.2 million hospital admissions in the U.S.
The ambulatory surgical centers segment is anticipated to witness a lucrative growth of 6.4% in the forecast period. The growth can be attributed to the fact that these centers are cost-effective as the surgery is performed on an outpatient basis and requires no overnight stay, there is a significant reduction in cost. There is an availability of a wide range of specialized services in these facilities. There is a lower risk of infection and contracting other illnesses in these centers due to the fewer number of patients.
North America dominated the global intubation tubes market in terms of the revenue share of 37.7% in 2022. The incidence of chronic and respiratory disorders including cancer and asthma is rising in the region. According to the Asthma and Allergy Foundation of America, in the U.S., about 20 million U.S. adults aged 18 and older have asthma and more than 25 million people have asthma. Approximately 40.4% of adults aged 18 and above who had asthma stated having more than one asthma attack in the past year in the U.S. in 2019. Europe held the second-largest share and is expected to show lucrative growth in the coming years.
Asia Pacific is expected to show the highest growth of 8.1% over the forecast period. The growth can be attributed to the increasing pollution causing respiratory diseases among the people and the growing aging population with chronic diseases in this region is further increasing the demand for surgeries.
The industry is marked by the presence of various industry players. The market is highly fragmented and competitive in nature. The industry growth is directly associated with the rising investments by manufacturers in the development of cost-effective, innovative products, and the rising prevalence of chronic diseases. The players are constantly involved in strategic initiatives such as acquisitions, new product launches, technological advancements, and collaborations in order to gain deeper penetration. For instance, in August 2022, Teleflex Incorporated announced the acquisition of Standard Bariatrics, Inc. which has commercialized an innovative powered stapling technology for bariatric surgery. The acquisition is likely to expand its surgical portfolio. Some of the prominent players in the global intubation tubes market include:
Teleflex Corporation
Medtronic
Medline Industries
Venner Medical
Sonoma Pharmaceutical
Hospiteknik Healthcare
Armstrong Medical
Airway Innovations
Smiths Group
ConvaTec, Inc.
Report Attribute |
Details |
Market size value in 2023 |
USD 2.7 billion |
Revenue forecast in 2030 |
USD 4.3 billion |
Growth rate |
CAGR of 6.7% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Market representation |
Revenue in USD million and CAGR from 2023 to 2030 |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country Scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; Denmark; Sweden; Norway; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Teleflex Corporation; Medtronic; Medline Industries; Venner Medical; Sonoma Pharmaceutical; Hospiteknik Healthcare; Armstrong Medical; Airway Innovations; Smiths Group; ConvaTec, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global intubation tubes market report based on product type, end-use, and region:
Product Type Outlook (Revenue, USD Million, 2018 - 2030)
Trachea Intubation
Gastric Intubation
End-Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global intubation tubes market size was estimated at USD 2.6 billion in 2022 and is expected to reach USD 2.7 billion in 2023.
b. The global intubation tubes market is expected to grow at a compound annual growth rate of 6.7% from 2023 to 2030 to reach USD 4.3 billion by 2030.
b. North America dominated the intubation tubes market with a share of 37.7% in 2022. This is attributable to the fact of the high prevalence of respiratory diseases in the region.
b. Some key players operating in the intubation tubes market include Teleflex Corporation, Medtronic, Medline Industries, Venner Medical, Sonoma Pharmaceutical, Hospiteknik Healthcare, Armstrong Medical, Airway Innovations, Smiths Group, and ConvaTec, Inc.
b. Key factors that are driving the intubation tubes market growth include the rising prevalence of chronic diseases and the increasing number of surgical procedures in the healthcare setting.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."